{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-008869","form_type":"8-K","ticker":"CLNN","cik":"0001822791","company_name":"Clene Inc.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.082369+00:00","generated_at":"2026-05-24T06:51:12.854942+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Clene reports FY2024 net loss $39.4M ($5.67/sh); plans NDA for CNM-Au8 in ALS in H2 2025","bullets":["Net loss $39.4M ($5.67/sh) vs. $49.5M ($9.43/sh) in FY2023.","Cash and marketable securities $12.2M at Dec 31, 2024; expected to fund ops into Q2 2025.","R&D expense $20.1M, down 25% YoY; G&A $13.3M, down 8%.","Planning NDA submission for CNM-Au8 in ALS in H2 2025; confirmatory Phase 3 RESTORE-ALS starts mid-2025.","Secured new $10M debt facility (12% interest, convertible at $5.67) replacing $7.85M Avenue debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-008869","json":"https://secwatch.observer/filing/0001437749-25-008869.json","markdown":"https://secwatch.observer/filing/0001437749-25-008869.md","text":"https://secwatch.observer/filing/0001437749-25-008869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822791/000143774925008869/0001437749-25-008869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822791/000143774925008869/clnn20240924_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:51:12.854942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}